Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomolecules and Therapeutics is Scopus-indexed (Q2, CiteScore 6.4), WoS SCIE. Published by Korean Society of Applied Pharmacology.
Checked against the index lists dated .
ISSN 1976-9148Verify ISSN ↗2005-4483Verify ISSN ↗
Publisher: Korean Society of Applied Pharmacology
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 95 / 328 | 71st | Q2 |
| Drug Discovery | 55 / 161 | 66th | Q2 |
| Biochemistry | 153 / 448 | 65th | Q2 |
| Molecular Medicine | 73 / 179 | 59th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 6.4.
Biomolecules and Therapeutics is Q2 in Pharmacology (rank 95 of 328), Q2 in Drug Discovery (rank 55 of 161) and Q2 in Biochemistry (rank 153 of 448), by CiteScore 2025. It is ranked in 4 subject areas in all.
Biomolecules and Therapeutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.4, which places it in quartile Q2 at the 71st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.969, quartile Q2, with an H-index of 66.
Biomolecules and Therapeutics is published by Korean Society of Applied Pharmacology. Its print ISSN is 1976-9148 and its online ISSN is 2005-4483.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomolecules and Therapeutics has an h-index of 71 and a 2-year mean of 3.69 citations per paper (OpenAlex). Its Scopus CiteScore is 6.4, quartile Q2. On 2-year citations it ranks #84 of 319 Scopus journals in Pharmacology.
Biomolecules and Therapeutics published 95 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from South Korea (72.9%), China (12.6%) and United States (3.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.